FSR Fisker Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

(RULE 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

Check the appropriate box:

Fisker Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

February 9, 2024

Dear Stockholder:

You are cordially invited to attend a special meeting of stockholders of Fisker Inc. (the “Company”). The special meeting will be held on Tuesday, March 5, 2024 at 8:00 a.m., Pacific Time, online via live webcast available at www.virtualshareholdermeeting.com/FSR2024SM (such meeting, including any adjournment or postponement thereof, the “Special Meeting”) for the following purposes:

1. To approve, for purposes of the rules of the New York Stock Exchange (the “NYSE”), the potential issuance of more than 19.99% of the outstanding shares of Class A Common Stock, par value $0.00001 per share (the “Class A Common Stock”), upon conversion of the Incremental Notes as described below (the “Stock Issuance Proposal”); and

2. To adopt an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended (the “Charter”) to increase the total number of shares of Class A Common Stock that the Company will have authority to issue from 1,250,000,000 shares to 2,000,000,000 shares (the “Authorized Shares Proposal” and, collectively with the Stock Issuance Proposal, the “Proposals”).

The form of amendment implementing the Authorized Shares Proposal is attached to this proxy statement as Annex A.

The Proposals are being submitted to the Company’s stockholders in connection with the transaction described below, which contemplates potential issuances of additional shares of Class A Common Stock by the Company upon conversion of the Incremental Notes (as defined below), which would require approval of our stockholders pursuant to Section 312.03 of the NYSE Listing Manual.

Specifically, on July 10, 2023, the Company entered into a Securities Purchase Agreement (the “Original Purchase Agreement”) with an institutional investor (the “Investor”) for a registered direct offering of $340,000,000 in aggregate principal amount of senior convertible notes due 2025 (the “Series A-1 Notes”). The Series A-1 Notes were issued at an original issue discount of approximately twelve percent (12%) resulting in gross proceeds to the Company of $300,000,000.

Pursuant to the terms of the Original Purchase Agreement, during a sixth-month period beginning on the one-year anniversary of the issuance of the Series A-1 Notes and ending on the eighteen-month anniversary of the issuance of the Series A-1 Notes (the “AIR Period”), the Investor could purchase up to an additional $226,666,667 in aggregate principal amount of senior convertible notes due two years after the date of issuance (the “Investor AIR Notes”) in one or more registered direct offerings. If the Investor elected, during the AIR Period, to purchase the full amount of Investor AIR Notes, the Company could, at its option, require the Investor to purchase up to an additional $113,333,333 in aggregate principal amount of senior convertible notes due two years after the date of issuance (the “Issuer AIR Notes” and, together with the Investor AIR Notes, the “Additional Notes”).

On August 30, 2023, we held a special meeting of stockholders where our stockholders approved the potential issuance of more than 19.99% of the outstanding shares of Class A Common Stock issuable upon conversion of (i) the $340,000,000 in aggregate principal amount of Series A-1 Notes and (ii) the $340,000,000 in aggregate principal amount of Additional Notes issuable pursuant to the Original Purchase Agreement.

On September 29, 2023, the Company and the Investor entered into Amendment No. 1 to the Original Purchase Agreement (the “Purchase Agreement Amendment” and, together with the Original Purchase

Agreement, the “Securities Purchase Agreement”), in order to, among other things:

On September 29, 2023, pursuant to the terms of the Securities Purchase Agreement, the Company issued $170,000,000 of Additional Notes, as Series B-1 senior convertible notes due 2025 (the “Series B-1 Notes”) in a registered direct offering to the Investor. The Series B-1 Notes were issued at an original issue discount of approximately twelve percent (12%) resulting in gross proceeds to the Company of $150,000,000. Both the Series A-1 Notes and the Series B-1 Notes were issued pursuant to that certain Indenture dated July 11, 2023, by and between the Company and Wilmington Savings Fund Society, FSB, as the trustee (the “Trustee”), as supplemented by that certain First Supplemental Indenture and Second Supplemental Indenture, respectively (collectively, the “Indenture”).

As a result of the Purchase Agreement Amendment, the Company may now offer an incremental $340,000,000 in aggregate principal amount of Investor AIR Notes and $113,333,334 in aggregate principal amount of Issuer AIR Notes (such incremental Investor AIR Notes and Issuer AIR Notes, the “Incremental Notes”). Given this increase in aggregate principal amount of Additional Notes that may be issued pursuant to the Securities Purchase Agreement, we have agreed to seek and obtain stockholder approval at a special meeting (no later than March 8, 2024), in order to (x) approve the potential issuance of more than 19.99% of the outstanding shares of Class A Common Stock upon conversion of the Incremental Notes in compliance with the rules and regulations of the NYSE and (y) increase the authorized shares of Class A Common Stock of the Company from 1,250,000,000 to 2,000,000,000.

On November 22, 2023, the Company, along with certain of its subsidiaries, and the Trustee entered into a third supplemental indenture (the “Third Supplemental Indenture”) to the Indenture pursuant to which, among other things, the Company agreed to secure the obligations under the Series A-1 and B-1 Notes pursuant to a pledge agreement dated as of November 22, 2023, in favor of the Investor as collateral agent (the “Original Pledge Agreement”) and a security agreement, to be entered into by and among the Company, the Investor and certain subsidiaries of the Company and such other security documents and certificates as specified in the Original Pledge Agreement, including guaranties executed by certain subsidiaries of the Company. Subsequently, on December 28, 2023, the Company and certain of its direct and indirect wholly owned subsidiaries entered into an Amended and Restated Security and Pledge Agreement (the “Amended Pledge Agreement”), in favor of the Investor as collateral agent, pursuant to which the entirety of the Original Pledge Agreement was amended and restated to, among other things, amend and define the scope of the security interest created by the Original Pledge Agreement in all of the existing and future assets of the Company and certain of its subsidiaries. In addition, on December 28, 2023, certain subsidiaries of the Company entered into a guaranty agreement (the “Guaranty”) in favor of the Investor as collateral agent, pursuant to which, among other things, such subsidiaries have guaranteed the Company’s outstanding obligations in respect of the Notes. This summary is qualified in its entirety by reference to the full text of the form of Third Supplemental Indenture, which is attached as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023 and to the form of Amended and Restated Security and Pledge Agreement and form of Guaranty, each of which is attached as an exhibit to the Company’s Current Report on Form 8-K filed on December 28, 2023.

On January 21, 2024, the Company and the Investor entered into a Second Amendment and Waiver Agreement (the “Second Waiver”), pursuant to which, among other things: (i) in connection with one or more future transactions with a strategic automotive partner, the Company has secured a release of all liens previously granted to the Investor on the intellectual property required by any such transactions, (ii) all financial covenants relating to the Company’s cash reserves were waived, and such unrestricted cash is now available for use in the operations of the Company; and (iii) the Company obtained a waiver of the use by the Investor of any remaining remedies arising from the Company’s previous late filing of its quarterly report on Form 10-Q for the quarter

ended September 30, 2023. This summary is qualified in its entirety by reference to the full text of the Second Waiver, the form of which is attached as an exhibit to the Company’s Current Report on Form 8-K filed on January 22, 2024.

The number of shares of Class A Common Stock underlying the Incremental Notes cannot be conclusively determined as of the date of this proxy statement since this number will be based on, among other things, the consideration which the Investor elects to receive for the Incremental Notes. While such number is uncertain, 390,804,598 shares of Class A Common Stock are issuable from time to time upon conversion or otherwise under the Incremental Notes, assuming we issue the full amount of the Incremental Notes and such Incremental Notes are converted at the Floor Price (as defined in the Notes), which would exceed the threshold set forth under Section 312.03 of the NYSE Listing Manual.

The Board of directors of the Company (the “Board”) has: (a) approved, adopted and ratified the consummation by the Company of the transactions described above and (b) recommended that the Company’s stockholders approve the Proposals at the Special Meeting. Accordingly, the Board recommends that you vote “FOR” each of the Proposals.

The close of business on February 8, 2024 is the record date for determining stockholders who are entitled to receive notice of, and to vote at, the Special Meeting. This Notice of Special Meeting and the accompanying proxy statement are first being distributed on or about February 9, 2024. Our principal executive offices are located at 1888 Rosecrans Avenue, Manhattan Beach, California 90266.

To provide convenient access and promote attendance and participation at the Special Meeting, we will hold the Special Meeting virtually. Stockholders may attend the Special Meeting by logging in at www.virtualshareholdermeeting.com/FSR2024SM. Please see page 5 of this proxy statement for additional information regarding participation in the Special Meeting.

Your vote is very important to us. Please submit your proxy as soon as possible to ensure that your shares are represented at the Special Meeting.

You can ensure your shares are represented at the Special Meeting if you are a stockholder of record by promptly voting electronically over the Internet or by returning your completed proxy card in the pre-addressed, postage-paid return envelope, or, if your shares are held in street name, by returning your completed voting instruction card to your broker. The proxy is solicited on behalf of the Board.

Sincerely,

Henrik Fisker

Chairman of the Board, President and Chief Executive Officer

TABLE OF CONTENTS

-i-

BACKGROUND

We are furnishing you this proxy statement (the “Proxy Statement”) in connection with a special meeting of the stockholders of the Company that will be held on Tuesday, March 5, 2024 at 8:00 a.m., Pacific Time (such meeting, including any adjournment or postponement thereof, the “Special Meeting”). The Special Meeting will be conducted online via live webcast.

The Special Meeting can be accessed via the Internet by visiting www.virtualshareholdermeeting.com/FSR2024SM. The information contained in, or that can be accessed through, our website is not a part of, or incorporated by reference in, this Proxy Statement.

Unless stated otherwise or the context indicates otherwise, references to “Fisker,” “we,” “us” and “our” are to the business of Fisker Inc., a Delaware corporation, and references to the “Company” are to Fisker Inc. alone.

1

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Proxy Statement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are forward-looking and as such are not historical facts. These forward-looking statements include, without limitation, statements regarding future financial performance, business strategies, expansion plans, future results of operations, estimated revenues, losses, projected costs, prospects, plans and objectives of management. These forward-looking statements are based on our management’s current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this report may include, for example, statements about:

The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the

2

section entitled “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022, as supplemented by reports subsequently filed with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all such risk factors, nor can we assess the effect of all such risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

3

QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING

The following are answers to some questions that you, as a stockholder, may have regarding the Special Meeting and the Proposals. The Company urges you to carefully read the remainder of this Proxy Statement because the information in this section does not provide all the information that might be important to you with respect to the Special Meeting and the Proposals.

1. Why am I receiving these proxy materials?

You are receiving this Proxy Statement and proxy card from the Company because, at the close of business on February 8, 2024, the record date for the Special Meeting, you were a holder of record of shares of Common Stock of the Company. This Proxy Statement describes the matters that will be presented for your consideration at the Special Meeting. It also gives you information concerning the matters to assist you in making an informed decision. We are calling the Special Meeting to approve the Authorized Shares Proposal and the Stock Issuance Proposal.

2. What am I voting on?

The Company’s stockholders are being asked to approve:

The form of amendment implementing the Authorized Shares Proposal is attached to this Proxy Statement as Annex A.

3. What will happen if the Proposals are not approved?

Unless we obtain the approval of our stockholders in accordance with the rules and regulations of the NYSE, a maximum of 77,068,750 shares of our Class A Common Stock (19.99% of the outstanding shares of our Class A Common Stock on January 23, 2024) will be issuable upon conversion or otherwise pursuant to the terms of the Incremental Notes.

If we are unable to obtain approval of the Stock Issuance Proposal, we will be unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes, as applicable, to the extent such issuance would exceed 19.99% of the outstanding shares of our Class A Common Stock. If we are unable to obtain approval of the Authorized Shares Proposal, we will be unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes to the extent such issuance would exceed the total number of shares authorized pursuant to our Charter. If we are unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes, on the terms currently contemplated, we may consider strategic alternatives to strengthen our liquidity position. These alternatives may include (subject to market conditions) capital markets transactions, repurchases, redemptions, exchanges or other refinancings of our existing debt, the potential issuance of equity securities, the potential sale of additional assets and businesses and/or other strategic transactions and/or other measures. These alternatives involve significant uncertainties, potential significant delays, costs and other risks, and there can be no assurance that any of these alternatives will be available on acceptable terms, or at all, in the current market environment or in the foreseeable future.

4. Does the Board and the Company’s management support the Proposals?

The Board and the Company’s management support the Proposals and believe them to be in the best interests of the Company and our stockholders. If the Proposals are not approved, we may need to consider other alternatives that may or may not be available to us to strengthen our liquidity position. These alternatives may

4

include (subject to market conditions) capital markets transactions, repurchases, redemptions, exchanges or other refinancings of our existing debt, the potential issuance of equity securities, the potential sale of additional assets and businesses, or other strategic transactions and measures. These alternatives involve significant uncertainties, potential significant delays, costs and other risks, and there can be no assurance that any of these alternatives will be available on acceptable terms, or at all, in the current market environment or in the foreseeable future.

The Board recommends that you vote in favor of the Proposals at the Special Meeting.

5. How will the Special Meeting be conducted?

The Special Meeting will be conducted online via live webcast. Stockholders may attend the meeting regardless of location.

6. How can I participate in the Special Meeting?

The Special Meeting will be conducted virtually via live webcast available at www.virtualshareholdermeeting.com/FSR2024SM. You are entitled to participate in the Special Meeting if you were a stockholder on February 8, 2024 (the “Record Date”) or hold a valid proxy for the Special Meeting.

To be admitted to the Special Meeting via live webcast, you must enter the 16-digit control number found next to the label “Control Number” on your Notice/proxy card. If you do not have your 16-digit control number, you will be able to login as a guest but will not be able to vote your shares during the Special Meeting.

You may begin to log in to the meeting platform beginning at 7:45 a.m., Pacific Time, on March 5, 2024. The meeting will begin promptly at 8:00 a.m., Pacific Time, on March 5, 2024.

7. What if I experience technical difficulties?

If you encounter any technical difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number posted on the Virtual Stockholder Meeting log in page. Technical support will be available starting at 7:45 a.m., Pacific Time on March 5, 2024.

8. Who is entitled to vote at the Special Meeting?

Stockholders of record as of the close of business on the Record Date are entitled to receive notice of, to attend and participate, and to vote at the Special Meeting. At the close of business on the Record Date, there were 402,816,178 shares of Class A Common Stock and 132,354,128 shares of Class B Common Stock outstanding and entitled to vote.

Stockholder of Record: Shares Registered in Your Name

If your shares are registered directly in your name with our transfer agent, Computershare Trust Company (“Computershare”), you are considered the stockholder of record with respect to those shares, and the Notice or these proxy materials will be sent directly to you by Fisker.

Beneficial Owner of Shares Held in Street Name: Shares Registered in the Name of a Broker or Nominee

If your shares are held in an account at a brokerage firm, bank, broker-dealer, or other similar organization, then you are the “beneficial owner” of shares held in “street name” and the Notice or these proxy materials were forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Special Meeting. As a beneficial owner, you have the right to instruct that organization on how to vote the shares held in your account. Because you are not the stockholder of record, you

5

may not vote your shares at the Special Meeting unless you request and obtain a valid proxy from the organization that holds your shares giving you the right to vote the shares at the Special Meeting. Beneficial owners must obtain a valid proxy from the organization that holds their shares and present it to Computershare at least three business (3) days in advance of the Special Meeting.

9. Who is soliciting my vote pursuant to this Proxy Statement and who will bear the cost of this proxy solicitation?

The proxy for the Special Meeting is being solicited on behalf of our Board. We will pay the cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. We may, on request, reimburse brokerage firms and other nominees for their expenses in forwarding proxy materials to beneficial owners. In addition to soliciting proxies by mail, we expect that our directors, officers and employees may solicit proxies in person or by telephone or facsimile. None of these individuals will receive any additional or special compensation for doing this, although we may reimburse these individuals for their reasonable out-of-pocket expenses. We do not expect to, but have the option to, retain a proxy solicitor. If you choose to access the proxy materials or vote via the Internet or by phone, you are responsible for any Internet access or phone charges you may incur.

10. How can I vote my shares of Common Stock at the Special Meeting?

You may vote by mail or follow any alternative voting procedure (such as telephone or internet voting) described on your proxy card. To use an alternative voting procedure, follow the instructions on each Notice and/or proxy card that you receive. The procedures for voting are as follows:

Stockholder of Record: Shares Registered in Your Name

If you are a stockholder of record, you may:

Votes submitted by telephone or through the internet must be received by 11:59 p.m. Eastern Time, on March 4, 2024. Submitting your proxy, whether by telephone, through the internet or by mail if you request or received a paper proxy card, will not affect your right to vote in person should you decide to attend and participate in the meeting virtually.

Beneficial Owner: Shares Registered in the Name of a Broker or Other Nominee

If you are not the stockholder of record, please refer to the voting instructions provided by your nominee to direct it how to vote your shares. Your vote is important. To ensure that your vote is counted, complete and mail the voting instruction card provided by your brokerage firm, bank, or other nominee as directed by your nominee. To electronically vote in person at the meeting online, you must obtain a legal proxy from your nominee. Follow the instructions from your nominee included with our proxy materials or contact your nominee to request a proxy form.

6

Your vote is important. Whether or not you plan to participate in the Special Meeting, we urge you to vote by proxy to ensure that your vote is counted.

11. What are my voting choices?

You may vote “FOR” or “AGAINST” or you may “ABSTAIN” from voting on any proposal to be voted on at the Special Meeting. Your shares will be voted as you specifically instruct. If you sign your proxy card without giving specific instructions on how your shares are to be voted at the Special Meeting, your shares will be voted in accordance with the recommendation of the Board in favor of each Proposal presented at the Special Meeting.

12. Can I change or revoke my vote after I return my proxy card?

You may change your vote or revoke your proxy at any time prior to the taking of the vote or the polls closing at the Special Meeting.

If you are the stockholder of record, you may change your vote by:

Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to revoke a proxy, you must contact that firm to revoke any prior voting instructions.

13. What vote is required for approval of the Proposals?

The Company’s bylaws (the “Bylaws”) provide that the holders of a majority in voting power of the issued and outstanding shares of the capital stock of the Company and entitled to vote at the Special Meeting, present in person or represented by proxy, constitute a quorum for the transaction of business at the Special Meeting. Shares that are authorized to be voted on or to abstain on any matter presented at the Special Meeting, or that are held by stockholders who are present at the Special Meeting, are counted as present and entitled to vote and are therefore included for purposes of determining whether a quorum is present at the Special Meeting. If you hold your Class A Common Stock or Class B Common Stock through a broker, the broker may be prevented from voting shares held in your brokerage account if you have not given the broker voting instructions with respect to your shares (resulting in what is referred to as a “broker non-vote”). Thus, it is important that you vote your shares to ensure that they are represented on all matters presented at the Special Meeting. For each of the proposals, the voting standard that will be applied to determine whether the proposals have been adopted, the Board’s recommendation, and treatment of abstentions and broker non-votes are as follows:

7

14. Am I entitled to dissenters’ rights or appraisal rights?

None of the Company’s stockholders are entitled to dissenters’ or appraisal rights with respect to any of the Proposals being submitted to the stockholders at the Special Meeting.

15. What happens if I do not respond or if I respond and fail to indicate my voting preference?

If you fail to attend the Special Meeting or are not represented by proxy at the Special Meeting, your shares will not be counted toward establishing a quorum for the Special Meeting, which requires that stockholders holding at least a majority of the voting power of the shares of our issued and outstanding Class A Common Stock and our Class B Common Stock (voting together as a single class), entitled to vote are present at the Special Meeting or represented by proxy.

If you respond and do not indicate your voting preference, your shares will be voted in accordance with the recommendation of the Board in favor of each Proposal presented at the Special Meeting.

16. Can I vote on other matters?

The Special Meeting has been called only to consider and vote on the approval of the Authorized Shares Proposal and the Stock Issuance Proposal. Under the Bylaws, no other matters may be considered at the Special Meeting if they are not included in this Proxy Statement, which serves as the notice of the Special Meeting.

17. Why were my proxy materials included in the same envelope as other people at my address?

The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process is commonly referred to as “householding.”

Brokers with account holders who are Fisker stockholders may be householding our proxy materials. A single set of proxy materials may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that it will be householding communications to your address, householding will continue until you are notified otherwise or until you notify your broker or Fisker that you no longer wish to participate in householding.

If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, you may (1) notify your broker, (2) direct your written request to: Investor Relations, Fisker Inc., 1888 Rosecrans Avenue, Manhattan Beach, California 90266 or (3) contact our Investor Relations department by email at fisker_ir@fiskerinc.com. Stockholders who receive multiple copies of the Proxy Statement at their address and would like to request householding of their communications should contact their broker. In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of the Proxy Statement to a stockholder at a shared address to which a single copy of the document was delivered.

8

18. What do I need to do now?

We urge you to read this Proxy Statement carefully and then either vote online at www.virtualshareholdermeeting.com/FSR2024SM by following the voting instructions on the proxy card or mail your dated and signed proxy card in the enclosed return envelope as soon as possible so that your shares can be voted in connection with the Special Meeting.

19. Who can help answer my other questions?

If you have more questions on the Proposals or voting, or if you need additional copies of this Proxy Statement or the enclosed proxy card you should contact Fisker’s Corporate Secretary at Fisker Inc., 1888 Rosecrans Avenue, Manhattan Beach, California 90266.

9

PURPOSE OF THE SPECIAL MEETING; BACKGROUND OF THE PROPOSALS

Background

Fisker is building a technology-enabled, capital-light automotive business model that we believe will be among the first of its kind and aligned with the future state of the automotive industry. This involves innovations in vehicle development, customer experience, and sales and service that improve the personal mobility experience through technological innovation, ease of use and flexibility. The Company brings the legendary design and product development expertise of Henrik Fisker—the visionary behind such iconic vehicles as the BMW Z8 sports car and the famed Aston Martin DB9 and V8 Vantage—to deliver high quality, sustainable, affordable electric vehicles that create a strong emotional connection with customers. Central to our business model is the Fisker Flexible Platform Agnostic Design, a proprietary process that allows the design and development of a vehicle to be adapted to any given EV platform in the specific segment size. The process focuses on creating industry leading vehicle designs that can be adapted to match the crucial hard points on an EV platform initially developed by a third-party. This, combined with rapid decision-making, focused supply chain management and outsourced manufacturing, reduces development cost and time to market, creating a new business model for the industry and one that gives Fisker a significant advantage in bringing vehicles to market faster, more efficiently, and with more modern and advanced technology than many competitors.

We had several business updates in August, September, October, and November 2023, including (i) the opening of the flagship customer lounge in Los Angeles, New York and several other cities across the United States and Europe; (ii) commencing global test drive events; (iii) the publishing of our annual ESG impact report; (iv) the achievement of producing over 10,000 vehicles; (v) the delivery of over 4,000 vehicles in 12 countries; (vi) completion of the homologation process in the US and Europe for the Fisker Ultra trim; (vii) bolstering the balance sheet with a successful offering of $170.0 million in aggregate principal of 0% senior convertible notes due in 2025; (viii) the adjustment of Fisker Ocean Extreme, Ultra, and Sport trim pricing.

Our focus during this industrialization phase is to ensure process readiness, tooling maturity, part validation, volume ramp up, software maturity, and streamline logistics. Our suppliers are subject to external factors that could impact their ability to ramp output of components for our vehicles at high quality levels. For example, during the third quarter, one supplier experienced financial hardship and Fisker provided financial assistance to support our production needs. Our key supply chain partners are concentrated within an umbrella group of companies, and we are dependent upon their operational performance. Our ability to reach expected run rates is contingent upon key suppliers’ ability to mature software and components and the ability of our manufacturing partner to successfully ramp production at required quality levels. We continue to work with our suppliers and our manufacturing partner as we prepare for higher volumes in 2024.

Transaction

The conversion of the Incremental Notes contemplates potential issuances of additional shares of Class A Common Stock by the Company, which would require approval of our stockholders pursuant to Section 312.03 of the NYSE Listing Manual.

Specifically, on July 10, 2023, the Company entered into the Original Purchase Agreement whereby the Company issued to the Investor $340,000,000 in aggregate principal amount of Series A-1 Notes. The Series A-1 Notes were issued at an original issue discount of approximately twelve percent (12%) resulting in gross proceeds to the Company of $300,000,000.

Pursuant to the terms of the Original Purchase Agreement, during a sixth-month period beginning on the one-year anniversary of the issuance of the Series A-1 Notes and ending on the eighteen-month anniversary of the issuance of the Series A-1 Notes, the Investor could purchase up to an additional $226,666,667 in aggregate principal amount of Investor AIR Notes in one or more registered direct offerings. If the Investor elected, during the AIR Period, to purchase the full amount of Investor AIR Notes, the Company could, at its option, require the Investor to purchase up to an additional $113,333,333 in aggregate principal amount of Issuer AIR Notes.

10

On August 30, 2023, we held a special meeting of stockholders where our stockholders approved the potential issuance of more than 19.99% of the outstanding shares of Class A Common Stock pursuant to the conversion of (i) the $340,000,000 in aggregate principal amount of Series A-1 Notes and (ii) the $340,000,000 in aggregate principal amount of Additional Notes issuable pursuant to the Original Purchase Agreement.

On September 29, 2023, the Company and the Investor entered into Purchase Agreement Amendment in order to, among other things:

On September 29, 2023, pursuant to the terms of the Securities Purchase Agreement, the Company issued $170,000,000 of Series B-1 Notes in a registered direct offering to the Investor. The Series B-1 Notes were issued at an original issue discount of approximately twelve percent (12%) resulting in gross proceeds to the Company of $150,000,000. Both the Series A-1 Notes and the Series B-1 Notes were issued pursuant to the Indenture.

As a result of the Purchase Agreement Amendment, the Company may now offer an incremental $340,000,000 in aggregate principal amount of Investor AIR Notes and $113,333,334 in aggregate principal amount of Issuer AIR Notes. Given this increase in aggregate principal amount of Additional Notes that may be issued pursuant to the Securities Purchase Agreement, we have agreed to seek and obtain stockholder approval at a special meeting (no later than March 8, 2024), in order to (x) approve the potential issuance of more than 19.99% of the outstanding shares of Class A Common Stock upon conversion of the Incremental Notes in compliance with the rules and regulations of the NYSE and (y) increase the authorized shares of the Class A Common Stock of the Company from 1,250,000,000 to 2,000,000,000.

On November 22, 2023, the Company, along with certain of its subsidiaries, and the Trustee entered into the Third Supplemental Indenture, pursuant to which, among other things, the Company agreed to secure the obligations under the Series A-1 and B-1 Notes pursuant to the Original Pledge Agreement and a security agreement, to be entered into by and among the Company, the Investor and certain subsidiaries of the Company and such other security documents and certificates as specified in the Original Pledge Agreement, including guaranties executed by certain subsidiaries of the Company. Subsequently, on December 28, 2023, the Company and certain of its direct and indirect wholly owned subsidiaries entered into the Amended Pledge Agreement, in favor of the Investor as collateral agent, pursuant to which the entirety of the Original Pledge Agreement was amended and restated to, among other things, amend and define the scope of the security interest created by the Original Pledge Agreement in all of the existing and future assets of the Company and certain of its subsidiaries. In addition, on December 28, 2023, certain subsidiaries of the Company entered into the Guaranty in favor of the Investor as collateral agent, pursuant to which, among other things, such subsidiaries have guaranteed the Company’s outstanding obligations in respect of the Notes. This summary is qualified in its entirety by reference to the full text of the form of Third Supplemental Indenture, which is attached as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023 and to the form of Amended and Restated Security and Pledge Agreement and form of Guaranty, each of which is attached as an exhibit to the Company’s Current Report on Form 8-K filed on December 28, 2023.

On January 21, 2024, the Company and the Investor entered into the Second Waiver, pursuant to which, among other things: (i) in connection with one or more future transactions with a strategic automotive partner, the Company has secured a release of all liens previously granted to the Investor on the intellectual property required by any such transactions, (ii) all financial covenants relating to the Company’s cash reserves were waived, and such unrestricted cash is now available for use in the operations of the Company; and (iii) the Company obtained a waiver of the use by the Investor of any remaining remedies arising from the Company’s previous late filing of its quarterly report on Form 10-Q for the quarter ended September 30, 2023. This summary is qualified in its entirety by reference to the full text of the Second Waiver, the form of which is attached as an exhibit to the Company’s Current Report on Form 8-K filed on January 22, 2024.

11

The number of shares of Class A Common Stock underlying the Incremental Notes cannot be conclusively determined as of the date of this proxy statement since this number will be based on, among other things, the consideration which the Investor elects to receive for the Incremental Notes. While such number is uncertain, 390,804,598 shares of Class A Common Stock are issuable from time to time upon conversion or otherwise under the Incremental Notes, assuming we issue the full amount of the Incremental Notes and such Incremental Notes are converted at the Floor Price (as defined in the Notes), which would exceed the threshold set forth under Section 312.03 of the NYSE Listing Manual.

The description of the material terms of the Series A-1 Notes, Series B-1 Notes, the Additional Notes, the Securities Purchase Agreement and the Indenture, as amended and supplemented from time to time does not purport to be complete and is subject to and is qualified by reference to all the provisions of the documents referenced above, including the definitions of certain terms used therein, which are filed in our Current Reports on Form 8-K filed with the SEC on July 10, 2023, September 29, 2023, December 28, 2023 and January 22, 2024 and our Quarterly Report on Form 10-Q filed with the SEC on November 22, 2023. We urge you to read these documents and the Securities Purchase Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 10, 2023 and the Purchase Agreement Amendment, which was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 29, 2023.

Recommendation of the Board

The Board (a) approved, adopted and ratified the consummation by the Company of the transactions described above; and (b) recommended that the Company’s stockholders approve the Proposals at the Special Meeting.

The Board recommends that you vote “FOR” each of the Proposals.

12

PROPOSAL 1—THE STOCK ISSUANCE PROPOSAL

The Board approved and recommends that the Company’s stockholders adopt a proposal to approve, for purposes of the rules of NYSE, the potential issuance of more than 19.99% of the outstanding shares, of Class A Common Stock upon conversion of the Incremental Notes. The number of shares of Class A Common Stock underlying the Incremental Notes cannot be conclusively determined as of the date of this proxy statement since this number will be based on, among other things, the consideration which the Investor elects to receive for the Incremental Notes. While such number is uncertain, 390,804,598 shares of Class A Common Stock are issuable from time to time upon conversion or otherwise under the Incremental Notes, assuming we issue the full amount of the Incremental Notes and such Incremental Notes are converted at the Floor Price (as defined in the Notes), which would exceed the threshold set forth under Section 312.03 of the NYSE Listing Manual.

Reason for Request for Stockholder Approval

The Class A Common Stock is listed on NYSE and, as a result, the Company is subject to the rules and regulations of NYSE. Section 312.03 of the NYSE Listing Manual requires an issuer to obtain stockholder approval prior to the issuance of common stock in any transaction or series of related transactions, if, among other things: (i) the common stock has, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such stock; or (ii) the number of shares of common stock to be issued is, or will be upon issuance, equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of common stock.

The approval of the Company’s stockholders is required because, in the event that the Investor elects to convert the Incremental Notes, the Company will be required to issue more than 19.99% of its currently outstanding Class A Common Stock in connection therewith.

The additional shares of Class A Common Stock that are proposed to be issued upon conversion of the Incremental Notes will have the same rights and privileges as the shares of Class A Common Stock currently authorized and outstanding. Holders of Common Stock are not entitled to preemptive rights to purchase Class A Common Stock or other securities or to cumulative voting rights in relation to the proposed issuance of shares of Class A Common Stock in connection with the conversion described above.

The Board believes that authorizing the issuance of additional shares of Class A Common Stock upon conversion of the Incremental Notes is fair to and in the best interests of the Company and the Company’s stockholders. For more information on the Incremental Notes and the transaction generally, see, “Purpose of the Special Meeting; Background of the Proposals.”

Effect of Vote in Favor for the Stock Issuance Proposal

A vote in favor of the Stock Issuance Proposal is a vote in favor of approving, for purposes of the rules of the NYSE, the issuance of shares of Class A Common Stock upon conversion of the Incremental Notes in an amount that exceeds 19.99% of its currently outstanding Class A Common Stock before the issuance of the Class A Common Stock. Approval of the Stock Issuance Proposal will allow us to, subject to the satisfaction of other conditions (including the approval of the Authorized Shares Proposal), issue shares of Class A Common Stock upon conversion of the Incremental Notes.

Approval of the Stock Issuance Proposal will not affect the rights of current holders of outstanding shares of Class A Common Stock. Approval will, however, allow us to, subject to the satisfaction of other conditions, issue a significant number of additional shares of Class A Common Stock. In the event that the Incremental Notes are converted into shares of Class A Common Stock, the issuance of such shares is expected to cause a significant dilution in the relative percentage interests of our current stockholders. Sales of substantial amounts of Class A Common Stock in the public market, or the perception that these sales could occur, coupled with the increase in

13

the outstanding number of shares of Class A Common Stock relative to shares of Class A Common Stock currently outstanding, could cause the market price of Class A Common Stock to decline. See “Security Ownership of Certain Beneficial Owners and Management” and “Risk Factors.”

Effect of Not Obtaining Required Vote for Approval of the Stock Issuance Proposal

If we are unable to obtain approval of the Stock Issuance Proposal, we will be unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes, as applicable, to the extent such issuance would exceed 19.99% of the outstanding shares of our Class A Common Stock. If we are unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes, as applicable, on the terms currently contemplated, we may consider strategic alternatives to strengthen our liquidity position. These alternatives may include (subject to market conditions) capital markets transactions, repurchases, redemptions, exchanges or other refinancings of our existing debt, the potential issuance of equity securities, the potential sale of additional assets and businesses and/or other strategic transactions and/or other measures. These alternatives involve significant uncertainties, potential significant delays, costs and other risks, and there can be no assurance that any of these alternatives will be available on acceptable terms, or at all, in the current market environment or in the foreseeable future.

Required Vote

Approval of the Stock Issuance Proposal requires the affirmative vote of the holders of a majority in voting power of the votes cast by holders of Common Stock. Abstentions and broker non-votes, if any, will have no effect on the vote on the Stock Issuance Proposal.

Recommendation of the Board

THE BOARD RECOMMENDS YOU VOTE “FOR” APPROVAL OF THE STOCK ISSUANCE PROPOSAL.

14

PROPOSAL 2—THE AUTHORIZED SHARES PROPOSAL

The Board approved, declared advisable and recommends that the Company’s stockholders approve a proposal to amend the Charter, in the form attached to this Proxy Statement as Annex A, to increase the total number of shares of Class A Common Stock that the Company will have authority to issue from 1,250,000,000 shares to 2,000,000,000 shares.

Reason for Request for Stockholder Approval

Article IV of the Charter currently authorizes the Company to issue 1,415,000,000 shares of total capital stock, comprising 1,250,000,000 shares of Class A Common Stock, 150,000,000 shares of Class B Common Stock and 15,000,000 shares of preferred stock, par value $0.00001 per share (the “Preferred Stock”). As of January 23, 2024, there were 385,536,519 shares of Class A Common Stock issued and outstanding.

Up to 390,804,598 shares of Class A Common Stock are issuable from time to time upon conversion or otherwise under the Incremental Notes, assuming we issue the full amount of the Incremental Notes and such Incremental Notes are converted at the Floor Price (as defined in the Notes). The number of shares that will be issued will depend on, among other things, the consideration which the Investor elects to receive, the consideration which the Company elects to use to make amortization payments under the Note and the conversion price for either of those instances.

The increase in authorized shares of Class A Common Stock will enable the Company to have the reserves required pursuant to the terms of the Securities Purchase Agreement and the Incremental Notes. We have not proposed the increase in the authorized number of shares of Class A Common Stock with the intention of using the additional shares for anti-takeover purposes, although we could theoretically use the additional shares to make more difficult or to discourage an attempt to acquire control of the Company.

The form of amendment implementing the Charter Amendment is attached to this Proxy Statement as Annex A.

Effect of Vote in Favor of the Authorized Shares Proposal

If the Authorized Shares Proposal is approved by the Company’s stockholders, the Company intends to file the Charter Amendment with the Secretary of State of Delaware as soon as practicable thereafter. The Board may, at any time prior to effectiveness, abandon the Charter Amendment without further action by the stockholders or the Board (even if the requisite stockholder vote is obtained).

Adoption of the Charter Amendment would increase the number of shares of Class A Common Stock that the Company will have authority to issue from 1,250,000,000 shares to 2,000,000,000 shares and, as a result, increase the number of shares of capital stock that the Company will have authority to issue from 1,415,000,000 shares to 2,165,000,000 shares. The number of shares of Class B Common Stock and Preferred Stock that the Company is authorized to issue would remain 150,000,000 shares and 15,000,000 shares, respectively. The Charter Amendment would amend and restate the text of Article IV of the Charter to read in full as follows:

“The total number of shares of all classes of stock that the Corporation has authority to issue is 2,165,000,000, consisting of three classes: 2,000,000,000 shares of Class A Common Stock, $0.00001 par value per share (“Class A Common Stock”), 150,000,000 shares of Class B Common stock, $0.00001 par value per share (“Class B Common Stock” and together with the Class A Common Stock, the “Common Stock”) and 15,000,000 shares of Preferred Stock, $0.00001 par value per share (“Preferred Stock”).”

The additional shares of Class A Common Stock authorized by the Charter Amendment would become part of the existing class of the Class A Common Stock and, if and when issued, would have the same rights and

15

privileges as the shares of Class A Common Stock currently authorized and outstanding. The Charter Amendment will not affect the par value of the Class A Common Stock, which will remain at $0.00001 per share. The additional shares of Class A Common Stock authorized by the Charter Amendment would not (and the shares of Class A Common Stock currently outstanding do not) entitle the holders thereof to preemptive rights to purchase Class A Common Stock or other securities or to cumulative voting rights.

Approval of the Authorized Shares Proposal will allow us to, subject to the satisfaction of other conditions (including the approval of the Stock Issuance Proposal), have the reserves required pursuant to the terms of the Securities Purchase Agreement and the Incremental Notes to issue the shares of Class A Common Stock underlying the Incremental Notes.

Effect of Not Obtaining Required Vote for Approval of the Authorized Shares Proposal

If we are unable to obtain approval of the Authorized Shares Proposal, we will be unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes to the extent such issuance would exceed the total number of shares authorized pursuant to our Charter. If we are unable to issue shares of Class A Common Stock upon conversion of the Incremental Notes, as applicable, on the terms currently contemplated, we may consider strategic alternatives to strengthen our liquidity position. These alternatives may include (subject to market conditions) capital markets transactions, repurchases, redemptions, exchanges or other refinancings of our existing debt, the potential issuance of equity securities, the potential sale of additional assets and businesses and/or other strategic transactions and/or other measures. These alternatives involve significant uncertainties, potential significant delays, costs and other risks, and there can be no assurance that any of these alternatives will be available on acceptable terms, or at all, in the current market environment or in the foreseeable future.

Required Vote

The Authorized Share Proposal will be adopted if it is approved by the affirmative vote of the holders of a majority of the voting power of the issued and outstanding Common Stock entitled to vote thereon. Abstentions and broker non-votes, if any, will have the same effect as a vote AGAINST the Authorized Shares Proposal.

Recommendation of the Board

THE BOARD RECOMMENDS YOU VOTE “FOR” APPROVAL OF THE AUTHORIZED SHARES PROPOSAL.

16

RISK FACTORS

In addition to the other information included in this Proxy Statement, you should read and carefully consider the following risks before deciding how to vote on the Proposals to be considered and voted upon at the Special Meeting. In addition, you should read and consider the risks associated with the businesses of the Company found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, particularly under the caption “Risk Factors,” as may be updated by any of the Company’s subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all of which are filed with the SEC. See “Cautionary Note Regarding Forward-Looking Statements” and “Additional Information—Where You Can Find More Information.”

Our Class B Stockholders have the most significant voting power in the Company and have interests in the transactions described herein that are different from, or in addition to, the interests of the other stockholders.

Shares of our Class B Common Stock have 10 votes per share, while shares of our Class A Common Stock have one vote per share. Henrik Fisker and Dr. Geeta Gupta-Fisker, Fisker’s co-founders, members of our Board and Chief Executive Officer and Chief Financial Officer, respectively, hold all of the issued and outstanding shares of our Class B Common Stock. Accordingly, Mr. Fisker and Dr. Gupta-Fisker hold approximately 77% of the voting power of Fisker’s capital stock on an outstanding basis and are able to control matters submitted to its stockholders for approval. So long as the Class B Stockholders retain their voting power, they will continue to have the ability to influence, directly or indirectly, and subject to applicable law, all matters affecting us, including:

Since the interests of the Class B Stockholders may differ from ours or from those of the Company’s other stockholders, actions that the Class B Stockholders take with respect to us, as the Company’s controlling stockholders, may not be favorable to us or our other stockholders, including holders of Class A Common Stock.

The Board was aware of and considered these interests, among other matters, in evaluating the transactions described herein and (a) approved, adopted and ratified the consummation by the Company of the transactions and (b) recommended that the Company’s stockholders approve the Proposals at the Special Meeting.

Controlling stockholders may exert influence over our management and affairs and control over votes requiring stockholder approval.

Certain stockholders own a significant portion of our Common Stock. Therefore, these entities may be able to exert influence over our management and policies and may have significant voting influence on votes requiring stockholder approval. This concentration of ownership may also have the effect of delaying, preventing or deterring a change of control of us, could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of us and might ultimately affect the market price of our common stock, should a market for our common stock develop.

17

The market price of shares of Class A Common Stock may decline in the future as a result of the sale of Class A Common Stock held by the Investor or other current holders of Class A Common Stock.

The Investor may receive a substantial number of shares of Class A Common Stock. The Investor may seek to sell their shares. Other stockholders may also seek to sell the shares of Class A Common Stock held by them following, or in anticipation of, completion of the transactions described herein. Sales of substantial amounts of Class A Common Stock in the public market, or the perception that these sales could occur, coupled with the increase in the outstanding number of shares of Class A Common Stock relative to shares of Class A Common Stock outstanding as of the date of this Proxy Statement, could cause the market price of Class A Common Stock to decline.

The terms of the Series A-1 Notes, Series B-1 Notes and the Additional Notes restrict our current and future operations, particularly our ability to respond to changes or take certain actions, including some of which may affect completion of our strategic plan.

The Series A-1, Series B-1 Notes and Additional Notes contain a number of restrictive covenants that impose operating restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to incur indebtedness, incur liens, enter into mergers or consolidations, dispose of assets, enter into affiliate transactions, pay dividends, make acquisitions and make investments, loans and advances.

These restrictions may affect our ability to execute on our business strategy, limit our ability to raise additional debt or equity financing to operate our business, including during economic or business downturns, and limit our ability to compete effectively or take advantage of new business opportunities.

The Company has incurred, and will continue to incur, significant costs in connection with the transactions described herein, which may be in excess of those anticipated by the Company.

The Company has incurred and will continue to incur substantial non-recurring costs and expenses in connection with the transactions described herein. These costs and expenses include, without limitation, expenses associated with its entry into the definitive documentation, costs and expenses of printing and mailing this Proxy Statement, and financial and legal advisory and other professional fees incurred related to the transactions. Furthermore, the cost to the Company of defending any potential litigation or other proceeding relating to the transactions could be substantial. These costs and expenses, as well as other unanticipated costs and expenses, could have an adverse effect on our financial condition and operating results.

Our obligations to the Investor pursuant to the Series A-1 and B-1 Notes are secured by a first priority security interest in all of the existing and future assets of the Company and certain of our subsidiaries, and if we default on those obligations, the Investor could foreclose on, liquidate and/or take possession of such assets. If that were to happen, we could be forced to curtail, or even to cease, our operations.

On December 28, 2023, the Company and certain of its direct and indirect wholly owned subsidiaries entered into the Amended Pledge Agreement, in favor of the Investor as collateral agent, pursuant to which the entirety of the Original Pledge Agreement was amended and restated to, among other things, amend and define the scope of the security interest created by the Original Pledge Agreement in all of the existing and future assets of the Company and certain of its subsidiaries. In addition, on December 28, 2023, certain subsidiaries of the Company entered into the Guaranty in favor of the Investor as collateral agent, pursuant to which, among other things, such subsidiaries have guaranteed the Company’s outstanding obligations in respect of the Notes. As a result, if we default on our obligations under the Series A-1 and B-1 Notes, the Investor could foreclose on their security interest and liquidate or take possession of some or all of the assets of the Company and certain of our subsidiaries, which would harm our business, financial condition and results of operations and could require us to curtail, or even to cease our operations.

18

The market price of shares of Class A Common Stock will continue to fluctuate.

The market price of shares of Class A Common Stock has fluctuated significantly in response to numerous factors and will continue to fluctuate, and holders of the Company’s Common Stock could lose some or all of the value of their investment.

The number of shares of Class A Common Stock that will be issued upon conversion of the Incremental Notes cannot be conclusively determined as of the date of this Proxy Statement, since this number will be based on, among other things, the consideration which the Investor elects to receive for such notes.

While the number of shares of Class A Common Stock that will be issued is uncertain, the issuance of shares upon conversion of the Incremental Notes in accordance with the terms thereof is expected to cause a significant dilution in the relative percentage interests of the Company’s stockholders and may lead to volatility in the price of shares of Class A Common Stock.

In addition, the stock market has experienced significant price and volume fluctuations in recent times, which, if they continue to occur, could have a significant adverse effect on the market for, or liquidity of, the shares of Class A Common Stock, regardless of the Company’s actual operating performance. Furthermore, the market price of shares of Class A Common Stock may fluctuate significantly in response to various factors, including, without limitation:

We are an early stage company with a history of losses, and expect to incur significant expenses and continuing losses in the future.

We have incurred a net loss since our inception. We believe that we will continue to incur operating and net losses each quarter until at least the time we begin significant deliveries of our vehicles. Even if we are able to successfully develop and sell or lease our vehicles, there can be no assurance that we will be commercially successful.

19

We expect we will incur losses in future periods as we, among other things, design, develop and manufacture our vehicles; build up inventories of parts and components for our vehicles; increase our sales and marketing activities, including opening new Fisker Experience Centers; develop our distribution infrastructure; and increase our selling, general and administrative functions to support our growing operations. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses.

In certain instances, NYSE may delist the Class A Common Stock from quotation on its exchange, which could limit investors’ ability to sell and purchase our securities and subject us to trading restrictions.

The Class A Common Stock is currently listed on the NYSE under the trading symbol “FSR.” However, if the price of shares of Class A Common Stock drops and if the average closing price of shares of Class A Common Stock is less than $1.00 over a consecutive 30 trading-day period the Class A Common Stock may be suspended and/or delisted in accordance with Section 802.01C of the NYSE’s Listed Company Manual. If the Class A Common Stock is not listed on the NYSE, we could face significant material adverse consequences, including:

If the Class A Common Stock becomes subject to the penny stock rules, it would become more difficult to trade our shares.

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not retain a listing on the NYSE, and if the price of the Class A Common Stock is less than $5.00, the Class A Common Stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for the Class A Common Stock, and therefore our stockholders may have difficulty selling their shares.

20

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information with respect to the beneficial ownership of our Common Stock as of January 23, 2024 by:

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares beneficially owned by them, subject to community property laws where applicable. Shares of our Common Stock subject to stock options or warrants that are currently exercisable or exercisable, and restricted stock units that vest, within 60 days of January 23, 2024 are deemed to be outstanding and to be beneficially owned by the person holding the stock options or warrants for the purpose of computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person.

Percentage ownership of our common stock is based on 385,536,519 shares of our Class A Common Stock and 132,354,128 shares of our Class B Common Stock outstanding on January 23, 2024. Unless otherwise indicated, the address of each of the individuals and entities named below is c/o Fisker Inc., 1888 Rosecrans Avenue, Manhattan Beach, California 90266.

21

22

23

ADDITIONAL INFORMATION

Annual Meeting Advance Notice Requirements and Stockholder Proposals

The Bylaws establish an advance notice procedure for stockholders wishing to directly nominate a director candidate or to present business to be conducted at the Company’s 2024 annual meeting of stockholders (“2024 Annual Meeting”). Among other things, in order for a stockholder to nominate a director candidate or to present a proposal at the 2024 Annual Meeting, the stockholder must deliver written notice of the nomination or proposal to the Company, or such notice must be mailed and received by the Company, no earlier than February 7, 2024, and no later than March 8, 2024, and the written notice must have complied with the requirements set forth in the Bylaws. However, if the date of the 2024 Annual Meeting is advanced by more than 30 days prior to, or delayed by more than 60 days after, the one-year anniversary of the date of the Company’s 2023 annual meeting of stockholders, then notice must be delivered or mailed and received no earlier than the 120th day prior to the 2024 Annual Meeting and no later than the 90th day prior to the 2024 Annual Meeting, or if later, the 10th day following the day on which public announcement of the date of such annual meeting is first made. For the nomination of a director candidate, the notice must contain prescribed information about the candidate and about the stockholder proposing the candidate, in accordance with the requirements set forth in the Bylaws.

In addition to satisfying the requirements of the Bylaws, including the notice deadlines set forth above and therein, to comply with the SEC’s universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must also comply with the additional requirements of Rule 14a-19 under the Exchange Act.

The Nominating and Corporate Governance Committee and the Board will consider director nominees properly recommended by stockholders and will evaluate each nominee based on the selection criteria listed in the Company’s corporate governance guidelines.

Stockholder Proposals under Rule 14a-8

Stockholders wishing to include a proposal in the proxy statement for the 2024 Annual Meeting pursuant to Rule 14a-8 under the Exchange Act must have timely delivered such proposal in writing to the Company by no later than December 29, 2023. Any such proposal must comply with the requirements of Rule 14a-8 under the Exchange Act.

Other Matters

According to our Bylaws, no business may be transacted at the Special Meeting other than the business specified in the notice of the Special Meeting.

Where You Can Find More Information

The Company files annual, quarterly, current reports and other information with the SEC. You may read and copy any document that the Company files with the SEC at the SEC’s website at www.sec.gov and on our website at investors.fiskerinc.com. The information found on, or that can be accessed from or that is hyperlinked to, our website is not a part of, or incorporated by reference in, this Proxy Statement. We are responsible for the information in this Proxy Statement and we have not authorized anyone else to provide you with information that is different or additional to the information provided in this Proxy Statement. You should not assume that the information in this Proxy Statement is accurate as of any date other than the mailing date of this Proxy Statement.

24

ANNEX A

CERTIFICATE OF AMENDMENT TO THE

SECOND AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

FISKER INC.

Pursuant to Section 242 of the

General Corporation Law of the State of Delaware

[●], 2024

FISKER INC. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify as follows:

The total number of shares of all classes of stock that the Corporation has authority to issue is 2,165,000,000 shares, consisting of three classes: 2,000,000,000 shares of Class A Common Stock, $0.00001 par value per share (“Class A Common Stock”), 150,000,000 shares of Class B Common Stock, $0.00001 par value per share (“Class B Common Stock” and together with the Class A Common Stock, the “Common Stock”) and 15,000,000 shares of Preferred Stock, $0.00001 par value per share (“Preferred Stock”).

IN WITNESS WHEREOF, the Corporation has caused this Amendment to the Second Amended and Restated Certificate of Incorporation to be duly executed by an authorized officer this [●] day of [●], 2024.

A-1

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:

V26654-S77007          KEEP THIS PORTION FOR YOUR RECORDS

— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —

DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

Important Notice Regarding the Availability of Proxy Materials for the Special Meeting:

The Notice and Proxy Statement is available at www.proxyvote.com.

— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —

V26655-S77007